Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Pharmaceutical industry

Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment

Editor's pick
BioPharma Dive
12 December 2018
African migrants

HIV clinic's hardest battle in treating people is helping them to overcome the social stigma

Editor's pick
Evening Standard
10 December 2018
Bad science & bogus treatments

Open letter from Chinese HIV professionals on human genome editing

Editor's pick
The Lancet
5 December 2018
Bad science & bogus treatments

As A Strategy for HIV Prevention, Disabling the CCR5 Gene in Embryos Implanted in HIV-Negative Mothers Makes Zero Sense

Editor's pick
NEJM Journal Watch
3 December 2018
Bad science & bogus treatments

Gene editing won’t help the fight against HIV, understanding one’s risk and prevention options will

Editor's pick
South China Morning Post
1 December 2018
Treatment guidelines

Brazil highlights treatment for all people with HIV

Editor's pick
World Health Organization
1 December 2018
Heterosexual men

Kenya: Riddle of gender disparities in HIV-Aids deaths

Editor's pick
Daily Nation
1 December 2018
Bad science & bogus treatments

Popular prostate cancer videos on YouTube 'inaccurate and biased'

Editor's pick
NHS Behind the Headlines
30 November 2018
New & experimental HIV treatments

European Commission Approves Merck’s DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ (doravirine)

Editor's pick
Merch press release
28 November 2018
Treatment simplification strategies

Dual HIV Regimen Equaled Triple Even After Treatment Failure

Editor's pick
MD Magazine
26 November 2018
Adherence

Substance use does not lower adherence to PrEP in MSM

Editor's pick
Healio
24 November 2018
Bad science & bogus treatments

GcMAF: Unlicensed HIV drug 'nearly killed patient'

Editor's pick
BBC News
23 November 2018
Cardiovascular disease

What triggered my heart attack?

Editor's pick
EATG
19 November 2018
New & experimental HIV treatments

Tivicay Plus Boosted Prezista Shows Promise as Two-Drug HIV Regimen

Editor's pick
Poz
16 November 2018
Treatment interruptions

Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults

Editor's pick
TAG
15 November 2018
Bad science & bogus treatments

Fake news, real consequences: What happens after headlines about false HIV 'cures'

Editor's pick
Bhekisisa
9 November 2018
Experiences of stigma

Linking HIV stigma, denial and poor health 

Editor's pick
AVERT
8 November 2018
Injectable & long-acting HIV treatment

ViiV’s Long-Acting Injectable HIV Regimen Boasts Good 3-Year Results

Editor's pick
Poz
5 November 2018
Cardiovascular disease

Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Editor's pick
Medscape (requires free registration)
1 November 2018
Starting treatment

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Editor's pick
Janssen press release
1 November 2018
Starting treatment

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
1 November 2018
Bad science & bogus treatments

'No cure' for HIV in Zimbabwe says UN, following claims from local preacher

Editor's pick
UN News
1 November 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
Adherence

How substance use affects adherence to PrEP among gay and bisexual men

Editor's pick
Medical Xpress
24 October 2018